Phase 1 study of the novel enhancer of zeste homolog 2 (EZH2) inhibitor GSK2816126 in patients with advanced hematological and solid tumors
Yap, Timothy A., Winter, Jane N, Giulino-Roth, Lisa, Longley, Jemma, Lopez, Juanita S, Michot, Jean-Marie, Leonard, John P., Ribrag, Vincent, McCabe, Michael T., Creasy, Caretha L., Stern, Melissa, PeLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-4121
Date:
August, 2019
File:
PDF, 973 KB
english, 2019